Close
Achema middle east
swop processing & packaging

UCB Wins Customer Innovation and Lifetime Value Achievement Awards for Improving Patient Experience

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research

Partnership delivers global, end-to-end solutions to accelerate genomics research Sapio...

Symeres acquiries DGr Pharma to enhance regulatory expertise and broaden its biopharma capabilities

Symeres, a leading global Contract Research, Development and Manufacturing...

Syntegon delivers strong growth and EBITDA improvements in first half of 2025

Successful growth strategy delivers sales growth in H1...

Two of UCB’s biggest patient innovators were announced as winners at the eyeforpharma Barcelona Awards for their long-term commitment to improve patient experiences.

Christi Marsh, Director of North American Medical Information and Communications and responsible for UCBCares, as well as departing CEO Roch Doliveux were commended for innovation and focus on the needs of patients.

Marsh won the Customer Innovator Award, while Doliveux joined Patrick Cashman of Lundbeck Canada as the second ever winner of the Lifetime Value Achievement Award.

UCBCares, which combines all call-centres and sources of patient and customer services under one number and office, was commended by 2014 winner of the Customer Innovator Award, John Pugh from Boehringer Ingelheim.

Patients are assigned a solutions manager to personally address their concerns from assistance, medical information and healthcare referrals to clinical study guidance and even non-UCB medication.

Nominated for the Lifetime Value Achievement Award for the second year in a row, Mr Doliveux is now recognised for developing UCB into a focused, patient-centric industry leader recognised for growth and a strong pipeline.

In 2012, Mr Doliveux unveiled UCB’s new tagline ‘Inspired by patients. Driven by science.’

The focus on empathy and innovation reflects the core of what UCB has become under Mr Doliveux’s leadership, with the company annually surveying all 9,000 staff to determine the level of patient-centric employee attitudes.

The awards both befit a consistent and determined approach to innovation, resilience and value creation over many years.

eyeforpharma chairman Paul Simms said: “Roch is very deserving of this award, showing that true innovation and patient-centricity in pharma should be driven right from the top of the business.

“His approach combines successful business with what truly matters in pharma: improving the lives of others.”

 

Latest stories

Related stories

Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research

Partnership delivers global, end-to-end solutions to accelerate genomics research Sapio...

Symeres acquiries DGr Pharma to enhance regulatory expertise and broaden its biopharma capabilities

Symeres, a leading global Contract Research, Development and Manufacturing...

Syntegon delivers strong growth and EBITDA improvements in first half of 2025

Successful growth strategy delivers sales growth in H1...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »